A citation-based method for searching scientific literature

Arati V Rao. Hematology Am Soc Hematol Educ Program 2016
Times Cited: 21







List of co-cited articles
145 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel.
Hartmut Döhner, Elihu Estey, David Grimwade, Sergio Amadori, Frederick R Appelbaum, Thomas Büchner, Hervé Dombret, Benjamin L Ebert, Pierre Fenaux, Richard A Larson,[...]. Blood 2017
57

International phase 3 study of azacitidine vs conventional care regimens in older patients with newly diagnosed AML with >30% blasts.
Hervé Dombret, John F Seymour, Aleksandra Butrym, Agnieszka Wierzbowska, Dominik Selleslag, Jun Ho Jang, Rajat Kumar, James Cavenagh, Andre C Schuh, Anna Candoni,[...]. Blood 2015
611
52

Multicenter, randomized, open-label, phase III trial of decitabine versus patient choice, with physician advice, of either supportive care or low-dose cytarabine for the treatment of older patients with newly diagnosed acute myeloid leukemia.
Hagop M Kantarjian, Xavier G Thomas, Anna Dmoszynska, Agnieszka Wierzbowska, Grzegorz Mazur, Jiri Mayer, Jyh-Pyng Gau, Wen-Chien Chou, Rena Buckstein, Jaroslav Cermak,[...]. J Clin Oncol 2012
713
52

Age and acute myeloid leukemia: real world data on decision to treat and outcomes from the Swedish Acute Leukemia Registry.
Gunnar Juliusson, Petar Antunovic, Asa Derolf, Sören Lehmann, Lars Möllgård, Dick Stockelberg, Ulf Tidefelt, Anders Wahlin, Martin Höglund. Blood 2009
597
42

Azacitidine prolongs overall survival compared with conventional care regimens in elderly patients with low bone marrow blast count acute myeloid leukemia.
Pierre Fenaux, Ghulam J Mufti, Eva Hellström-Lindberg, Valeria Santini, Norbert Gattermann, Ulrich Germing, Guillermo Sanz, Alan F List, Steven Gore, John F Seymour,[...]. J Clin Oncol 2010
702
33

Age and acute myeloid leukemia.
Frederick R Appelbaum, Holly Gundacker, David R Head, Marilyn L Slovak, Cheryl L Willman, John E Godwin, Jeanne E Anderson, Stephen H Petersdorf. Blood 2006
851
33

Parameters detected by geriatric and quality of life assessment in 195 older patients with myelodysplastic syndromes and acute myeloid leukemia are highly predictive for outcome.
Barbara Deschler, Gabriele Ihorst, Uwe Platzbecker, Ulrich Germing, Eva März, Marcelo de Figuerido, Kurt Fritzsche, Peter Haas, Helmut R Salih, Aristoteles Giagounidis,[...]. Haematologica 2013
137
28

Big data analysis of treatment patterns and outcomes among elderly acute myeloid leukemia patients in the United States.
Bruno C Medeiros, Sacha Satram-Hoang, Deborah Hurst, Khang Q Hoang, Faiyaz Momin, Carolina Reyes. Ann Hematol 2015
156
28

Genomic Classification and Prognosis in Acute Myeloid Leukemia.
Elli Papaemmanuil, Moritz Gerstung, Lars Bullinger, Verena I Gaidzik, Peter Paschka, Nicola D Roberts, Nicola E Potter, Michael Heuser, Felicitas Thol, Niccolo Bolli,[...]. N Engl J Med 2016
28

Geriatric assessment predicts survival for older adults receiving induction chemotherapy for acute myelogenous leukemia.
Heidi D Klepin, Ann M Geiger, Janet A Tooze, Stephen B Kritchevsky, Jeff D Williamson, Timothy S Pardee, Leslie R Ellis, Bayard L Powell. Blood 2013
220
28

Complete remission and early death after intensive chemotherapy in patients aged 60 years or older with acute myeloid leukaemia: a web-based application for prediction of outcomes.
Utz Krug, Christoph Röllig, Anja Koschmieder, Achim Heinecke, Maria Cristina Sauerland, Markus Schaich, Christian Thiede, Michael Kramer, Jan Braess, Karsten Spiekermann,[...]. Lancet 2010
205
23

Prediction of early death after induction therapy for newly diagnosed acute myeloid leukemia with pretreatment risk scores: a novel paradigm for treatment assignment.
Roland B Walter, Megan Othus, Gautam Borthakur, Farhad Ravandi, Jorge E Cortes, Sherry A Pierce, Frederick R Appelbaum, Hagop A Kantarjian, Elihu H Estey. J Clin Oncol 2011
204
23

Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia.
Timothy J Ley, Christopher Miller, Li Ding, Benjamin J Raphael, Andrew J Mungall, A Gordon Robertson, Katherine Hoadley, Timothy J Triche, Peter W Laird, Jack D Baty,[...]. N Engl J Med 2013
23

High-dose daunorubicin in older patients with acute myeloid leukemia.
Bob Löwenberg, Gert J Ossenkoppele, Wim van Putten, Harry C Schouten, Carlos Graux, Augustin Ferrant, Pieter Sonneveld, Johan Maertens, Mojca Jongen-Lavrencic, Marie von Lilienfeld-Toal,[...]. N Engl J Med 2009
571
23

How I treat the older patient with acute myeloid leukemia.
Gert Ossenkoppele, Bob Löwenberg. Blood 2015
132
23

Geriatric assessment in older patients with acute myeloid leukemia: a retrospective study of associated treatment and outcomes.
Alexander E Sherman, Gabriela Motyckova, K Rebecca Fega, Daniel J Deangelo, Gregory A Abel, David Steensma, Martha Wadleigh, Richard M Stone, Jane A Driver. Leuk Res 2013
64
23

Venetoclax combined with decitabine or azacitidine in treatment-naive, elderly patients with acute myeloid leukemia.
Courtney D DiNardo, Keith Pratz, Vinod Pullarkat, Brian A Jonas, Martha Arellano, Pamela S Becker, Olga Frankfurt, Marina Konopleva, Andrew H Wei, Hagop M Kantarjian,[...]. Blood 2019
679
23

TP53 and Decitabine in Acute Myeloid Leukemia and Myelodysplastic Syndromes.
John S Welch, Allegra A Petti, Christopher A Miller, Catrina C Fronick, Michelle O'Laughlin, Robert S Fulton, Richard K Wilson, Jack D Baty, Eric J Duncavage, Bevan Tandon,[...]. N Engl J Med 2016
440
19


CPX-351 (cytarabine and daunorubicin) Liposome for Injection Versus Conventional Cytarabine Plus Daunorubicin in Older Patients With Newly Diagnosed Secondary Acute Myeloid Leukemia.
Jeffrey E Lancet, Geoffrey L Uy, Jorge E Cortes, Laura F Newell, Tara L Lin, Ellen K Ritchie, Robert K Stuart, Stephen A Strickland, Donna Hogge, Scott R Solomon,[...]. J Clin Oncol 2018
355
19

The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia.
Daniel A Arber, Attilio Orazi, Robert Hasserjian, Jürgen Thiele, Michael J Borowitz, Michelle M Le Beau, Clara D Bloomfield, Mario Cazzola, James W Vardiman. Blood 2016
19

Epigenetic therapy is associated with similar survival compared with intensive chemotherapy in older patients with newly diagnosed acute myeloid leukemia.
Alfonso Quintás-Cardama, Farhad Ravandi, Theresa Liu-Dumlao, Mark Brandt, Stefan Faderl, Sherry Pierce, Gautam Borthakur, Guillermo Garcia-Manero, Jorge Cortes, Hagop Kantarjian. Blood 2012
156
19


Acute myeloid leukemia with translocation (8;21) or inversion (16) in elderly patients treated with conventional chemotherapy: a collaborative study of the French CBF-AML intergroup.
Thomas Prébet, Nicolas Boissel, Sarah Reutenauer, Xavier Thomas, Jacques Delaunay, Jean-Yves Cahn, Arnaud Pigneux, Bruno Quesnel, Francis Witz, Sylvain Thépot,[...]. J Clin Oncol 2009
87
14

Biologic vs physiologic age in the transplant candidate.
Andrew S Artz. Hematology Am Soc Hematol Educ Program 2016
20
15

The outcomes and costs of acute myeloid leukemia among the elderly.
Joseph Menzin, Kathleen Lang, Craig C Earle, Donna Kerney, Rajiv Mallick. Arch Intern Med 2002
215
14

Intensive induction is effective in selected octogenarian acute myeloid leukemia patients: prognostic significance of karyotype and selected molecular markers used in the European LeukemiaNet classification.
Meir Wetzler, Krzysztof Mrózek, Jessica Kohlschmidt, Hervé Dombret, Hartmut Döhner, Sylvain Pilorge, Utz Krug, Andrew J Carroll, Richard A Larson, Guido Marcucci,[...]. Haematologica 2014
29
14

Therapeutic advances in acute myeloid leukemia.
Alan Burnett, Meir Wetzler, Bob Löwenberg. J Clin Oncol 2011
550
14


Impairment in functional status and survival in patients with acute myeloid leukaemia.
Ulrich Wedding, Bernd Röhrig, Almuth Klippstein, Hans-Joerg Fricke, Herbert G Sayer, Klaus Höffken. J Cancer Res Clin Oncol 2006
68
14

Cladribine, but not fludarabine, added to daunorubicin and cytarabine during induction prolongs survival of patients with acute myeloid leukemia: a multicenter, randomized phase III study.
Jerzy Holowiecki, Sebastian Grosicki, Sebastian Giebel, Tadeusz Robak, Slawomira Kyrcz-Krzemien, Kazimierz Kuliczkowski, Aleksander B Skotnicki, Andrzej Hellmann, Kazimierz Sulek, Anna Dmoszynska,[...]. J Clin Oncol 2012
154
14

Treatment, trial participation and survival in adult acute myeloid leukemia: a population-based study in the Netherlands, 1989-2012.
A G Dinmohamed, O Visser, Y van Norden, N M A Blijlevens, J J Cornelissen, G A Huls, P C Huijgens, P Sonneveld, A A van de Loosdrecht, G J Ossenkoppele,[...]. Leukemia 2016
50
14

Anthracycline dose intensification in acute myeloid leukemia.
Hugo F Fernandez, Zhuoxin Sun, Xiaopan Yao, Mark R Litzow, Selina M Luger, Elisabeth M Paietta, Janis Racevskis, Gordon W Dewald, Rhett P Ketterling, John M Bennett,[...]. N Engl J Med 2009
610
14

Genetic alterations and their clinical implications in older patients with acute myeloid leukemia.
C-H Tsai, H-A Hou, J-L Tang, C-Y Liu, C-C Lin, W-C Chou, M-H Tseng, Y-C Chiang, Y-Y Kuo, M-C Liu,[...]. Leukemia 2016
73
14

Comorbidity is an independent predictor of complete remission in elderly patients receiving induction chemotherapy for acute myeloid leukemia.
Anne Etienne, Benjamin Esterni, Aude Charbonnier, Marie-Joëlle Mozziconacci, Christine Arnoulet, Diane Coso, Brigitte Puig, Jean-Albert Gastaut, Dominique Maraninchi, Norbert Vey. Cancer 2007
114
14

Addition of gemtuzumab ozogamicin to induction chemotherapy in adult patients with acute myeloid leukaemia: a meta-analysis of individual patient data from randomised controlled trials.
Robert K Hills, Sylvie Castaigne, Frederick R Appelbaum, Jacques Delaunay, Stephen Petersdorf, Megan Othus, Elihu H Estey, Hervé Dombret, Sylvie Chevret, Norbert Ifrah,[...]. Lancet Oncol 2014
356
14

Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet.
Hartmut Döhner, Elihu H Estey, Sergio Amadori, Frederick R Appelbaum, Thomas Büchner, Alan K Burnett, Hervé Dombret, Pierre Fenaux, David Grimwade, Richard A Larson,[...]. Blood 2010
14

Durable Remissions with Ivosidenib in IDH1-Mutated Relapsed or Refractory AML.
Courtney D DiNardo, Eytan M Stein, Stéphane de Botton, Gail J Roboz, Jessica K Altman, Alice S Mims, Ronan Swords, Robert H Collins, Gabriel N Mannis, Daniel A Pollyea,[...]. N Engl J Med 2018
584
14

Randomized comparison of low dose cytarabine with or without glasdegib in patients with newly diagnosed acute myeloid leukemia or high-risk myelodysplastic syndrome.
Jorge E Cortes, Florian H Heidel, Andrzej Hellmann, Walter Fiedler, B Douglas Smith, Tadeusz Robak, Pau Montesinos, Daniel A Pollyea, Pierre DesJardins, Oliver Ottmann,[...]. Leukemia 2019
227
14

Development and Validation of a Novel Acute Myeloid Leukemia-Composite Model to Estimate Risks of Mortality.
Mohamed L Sorror, Barry E Storer, Amir T Fathi, Aaron T Gerds, Bruno C Medeiros, Paul Shami, Andrew M Brunner, Mikkael A Sekeres, Sudipto Mukherjee, Esteban Peña,[...]. JAMA Oncol 2017
61
14

Intensive chemotherapy, azacitidine, or supportive care in older acute myeloid leukemia patients: an analysis from a regional healthcare network.
Pierre Bories, Sarah Bertoli, Emilie Bérard, Julie Laurent, Eliane Duchayne, Audrey Sarry, Eric Delabesse, Odile Beyne-Rauzy, Françoise Huguet, Christian Récher. Am J Hematol 2014
34
14

Age-related risk profile and chemotherapy dose response in acute myeloid leukemia: a study by the German Acute Myeloid Leukemia Cooperative Group.
Thomas Büchner, Wolfgang E Berdel, Claudia Haferlach, Torsten Haferlach, Susanne Schnittger, Carsten Müller-Tidow, Jan Braess, Karsten Spiekermann, Joachim Kienast, Peter Staib,[...]. J Clin Oncol 2009
238
14

Genetics of acute myeloid leukemia in the elderly: mutation spectrum and clinical impact in intensively treated patients aged 75 years or older.
Victoria V Prassek, Maja Rothenberg-Thurley, Maria C Sauerland, Tobias Herold, Hanna Janke, Bianka Ksienzyk, Nikola P Konstandin, Dennis Goerlich, Utz Krug, Andreas Faldum,[...]. Haematologica 2018
47
14

Acute Myeloid Leukemia, Version 3.2019, NCCN Clinical Practice Guidelines in Oncology.
Martin S Tallman, Eunice S Wang, Jessica K Altman, Frederick R Appelbaum, Vijaya Raj Bhatt, Dale Bixby, Steven E Coutre, Marcos De Lima, Amir T Fathi, Melanie Fiorella,[...]. J Natl Compr Canc Netw 2019
157
14


Postremission therapy in older patients with de novo acute myeloid leukemia: a randomized trial comparing mitoxantrone and intermediate-dose cytarabine with standard-dose cytarabine.
R M Stone, D T Berg, S L George, R K Dodge, P A Paciucci, P P Schulman, E J Lee, J O Moore, B L Powell, M R Baer,[...]. Blood 2001
158
9

Decision-making and quality of life in older adults with acute myeloid leukemia or advanced myelodysplastic syndrome.
M A Sekeres, R M Stone, D Zahrieh, D Neuberg, V Morrison, D J De Angelo, I Galinsky, S J Lee. Leukemia 2004
143
9

Age-specific differences in oncogenic pathway dysregulation and anthracycline sensitivity in patients with acute myeloid leukemia.
Arati V Rao, Peter J M Valk, Klaus H Metzeler, Chaitanya R Acharya, Sascha A Tuchman, Marvaretta M Stevenson, David A Rizzieri, Ruud Delwel, Christian Buske, Stefan K Bohlander,[...]. J Clin Oncol 2009
68
9


Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT.
Mohamed L Sorror, Michael B Maris, Rainer Storb, Frederic Baron, Brenda M Sandmaier, David G Maloney, Barry Storer. Blood 2005
9


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.